顶部联系方式

Time of issue:2018-03-12 00:00:00

Have Any Questions?  Mabspace BiosciencesInfo@mabspacebio.com 迈博斯生物0512-86861701

搜索
迈博斯生物

语言切换

Time of issue:2019-11-21 00:00:00
这是描述信息

COOPERATION

>>
Product License

Product License

  • Categories:Partnering
  • Time of issue:2019-11-23 00:00:00
  • Views:0
Description:
Description:
Information

MabSpace is seeking parnters for out-licensing of the ex-China rights of its lead therapeutic assets:

1) A second generation PD-L1 antibody with pH-dependent antigen binding and recylcing properties (starting FIH in 2017)

2) A best-in-class VEGFR2 neutralizing antibody at Pre-IND stage (FIH expected to start in 2018)

3) A best -in class OX40 agonist antibody in IND-enabling study

4) A best-in class CSF1R blocking antibody in IND-enabling study

Scan the QR code to read on your phone

页脚关于我们

Time of issue:2019-11-23 00:00:00

页脚管道

Time of issue:2019-11-23 00:00:00

页脚新闻

Time of issue:2019-11-23 00:00:00

页脚人力资源

Time of issue:2019-11-23 00:00:00

页脚联系方式

Time of issue:2019-11-23 00:00:00

页脚版权

Time of issue:2019-11-23 00:00:00

Copyright © 2019 Mabspace Biosciences All rights reserved

页脚备案

Time of issue:2019-11-23 00:00:00